Strell, Carina
Stenmark Tullberg, Axel
Jetne Edelmann, Reidunn
Akslen, Lars Andreas
Malmström, Per
Fernö, Mårten
Holmberg, Erik
Östman, Arne
Karlsson, Per http://orcid.org/0000-0003-4841-2672
Funding for this research was provided by:
Vetenskapsrådet
Cancerfonden (Can-2019/0081)
Radiumhemmets Forskningsfonder (174292, 2019:248)
University of Gothenburg
Article History
Received: 6 November 2020
Accepted: 5 February 2021
First Online: 4 March 2021
Compliance with ethical standards
:
: PK, EH, PM, MF research contract with PFS Genomics; AÖ received research support not related to the presented project from Eli-Lilly and Roche. CS, AST, RJN, LAA no disclosures.
: The study was approved by the Lund University Regional Ethical Review Board (approval numbers 2010/127 and 2015/548).
: Informed oral consent was obtained from all patients, which was determined appropriate and approved by the Ethical Review Board for the original trial and for this immunohistochemistry study.